Angiodynamics PE ratio ANGO

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 38.8×; Jan 2024
9-year median: 45.0×
9-year range: 5.9× to 177×
Peer median: 28.3×

Angiodynamics has no meaningful PE ratio today: it lost $0.78 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Jan 2024, at 38.8×.

On the days it had one over the last 9 years, its median was 45.0×, from 5.9× in Mar 2020 to 177× in Apr 2019.

PE ratio over time

median 45×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	38.8×	38.8×	38.8×
2023	49.0×	38.8×	49.8×
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	7.3×	5.9×	10.6×
2019	10.0×	8.9×	177×
2018	46.9×	44.7×	54.0×
2017	166×	117×	176×
2016	n/m a value too high to mean anything
2015	111×	110×	172×
2014	160×	127×	163×

Against its peers

Companies in Medical - Instruments & Supplies nearest Angiodynamics' size, closest first, today.

Company	PE ratio
ANGOAngiodynamics	n/m
TCMDTactile Systems Technology	21.9×
MDXGMimedx	97.8×
MOVMovado	17.5×
EMBCEmbecta	4.6×
INFUInfuSystem	34.0×
IRMDIradimed	47.9×
STAAStaar Surgical	323×
UTMDUtah Medical Products	22.6×
BVSBioventus	19.4×
CDRECadre	37.0×
Peer median	28.3×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Angiodynamics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.